Apigenin-induced nitric oxide production involves calcium-activated potassium channels and is responsible for antiangiogenic effects

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 8, 2007, Pages 1774-1781

  Erdogan, Ali ^a   Most, A K ^a   Wienecke, B ^a   Fehsecke, A ^a   Leckband, C ^a   Voss, R ^a   Grebe, M T ^a   Tillmanns, H ^a   Schaefer, C A ^a   Kuhlmann, Christopher R W ^a,b  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Apigenin; Endothelial cells; K+ channel

Indexed keywords

APAMIN; APIGENIN; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYCLIC GMP; FLUORESCENT DYE; IBERIOTOXIN; NITRIC OXIDE; PROTEIN KINASE B;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPERPOLARIZATION; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION;

ANGIOGENESIS INHIBITORS; APIGENIN; CALCIUM; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; PHOSPHORYLATION; POTASSIUM CHANNELS; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; TIME FACTORS; UMBILICAL VEINS;

EID: 34447643757     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02615.x     Document Type: Article

References (31)

1. Fotsis T, Pepper MS, Aktas E, Breit S, Rasku S, Adlercreutz H, Wahala K, Montesano R, Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res 1997; 57: 2916-21.
2. Olszanecki R, Gebska A, Kozlovski VI, Gryglewski RJ. Flavonoids and nitric oxide synthase. J Physiol Pharmacol 2002; 53: 571-84.
3. Piantelli M, Rossi C, Iezzi M, La Sorda R, Iacobelli S, Alberti S, Natali PG. Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J Cell Physiol 2006; 207: 23-9.
4. Kim MH. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. J Cell Biochem 2003; 89: 529-38.
5. Osada M, Imaoka S, Funae Y. Apigenin suppresses the expression of VEGF, an important factor for angiogenesis, in endothelial cells via degradation of HIF-1alpha protein. FEBS Lett 2004; 575: 59-63.
6. Fang J, Xia C, Cao Z, Zheng JZ, Reed E, Jiang BH. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J 2005; 19: 342-53.
7. Takano-Ishikawa Y, Goto M, Yamaki K. Inhibitory effects of several flavonoids on E-selectin expression on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha. Phytother Res 2003; 17: 1224-7.
8. Choi JS, Choi YJ, Park SH, Kang JS, Kang YH. Flavones mitigate tumor necrosis factor-alpha-induced adhesion molecule upregulation in cultured human endothelial cells: Role of nuclear factor-kappa B. J Nutr 2004; 134: 1013-9.
9. Gerritsen ME, Carley WW, Ranges GE, Shen CP, Phan SA, Ligon GF, Perry CA. Flavonoids inhibit cytokine-induced endothelial cell adhesion protein gene expression. Am J Pathol 1995; 147: 278-92.
10. Rossoni G, Grande S, Galli C, Visioli F. Wild artichoke prevents the age-associated loss of vasomotor function. J Agric Food Chem 2005; 53: 10291-6.
11. Zhang YH, Park YS, Kim TJ, Fang LH, Ahn HY, Hong JT, Kim Y, Lee CK, Yun YP. Endothelium-dependent vasorelaxant and antiproliferative effects of apigenin. Gen Pharmacol 2000; 35: 341-7.
12. Calderone V, Chericoni S, Martinelli C, Testai L, Nardi A, Morelli I, Breschi MC, Martinotti E. Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 290-8.
13. 2+ -entry into cultured human endothelial cells. Planta Med 2005; 71: 520-4.
14. Kuhlmann CR, Wu Y, Li F, Munz BM, Tillmanns H, Waldecker B, Wiecha J. bFGF activates endothelial Ca2+-activated K+ channels involving G-proteins and tyrosine kinases. Vascul Pharmacol 2004; 41: 181-6.
15. Kuhlmann CR, Lessmann V, Luhmann HJ. Fluvastatin stabilizes the blood brain barrier in vitro by nitric oxide dependent dephosphorylation of myosin light chains. Neuropharmacology 2006; 51: 907-13.
16. Kuhlmann CR, Schaefer CA, Reinhold L, Tillmanns H, Erdogan A. Signalling mechanisms of SDF-induced endothelial cell proliferation and migration. Biochem Biophys Res Commun 2005; 335: 1107-14.
17. Kuhlmann CR, Scharbrodt W, Schaefer CA, Most AK, Backenkohler U, Neumann T, Tillmanns H, Waldecker B, Erdogan A, Wiecha J. Discordant effects of nicotine on endothelial cell proliferation, migration, and the inward rectifier potassium current. J Mol Cell Cardiol 2005; 38: 315-22.
18. Erdogan A, Schaefer CA, Schaefer M, Luedders DW, Stockhausen F, Abdallah Y, Schaefer C, Most AK, Tillmanns H, Piper HM, Kuhlmann CR. Margatoxin inhibits VEGF-induced hyperpolarization, proliferation and nitric oxide production of human endothelial cells. J Vasc Res 2005; 42: 368-76.
19. Kuhlmann CR, Schaefer CA, Fehsecke A, Most AK, Tillmanns H, Erdogan A. A new signaling mechanism of hepatocyte growth factor-induced endothelial proliferation. J Thromb Haemost 2005; 3: 2089-95.
20. Nilius B, Droogmans G. Ion channels and their functional role in vascular endothelium. Physiol Rev 2001; 81: 1415-59.
21. Wang H, Lin L, Jiang J, Wang Y, Lu ZY, Bradbury JA, Lih FB, Wang DW, Zeldin DC. Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways. J Pharmacol Exp Ther 2003; 307: 753-64.
22. Adams DJ, Barakeh J, Laskey R, Van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J 1989; 3: 2389-400.
23. Lückhoff A, Busse R. Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflügers Arch 1990; 416: 305-11.
24. Schafer M, Bahde D, Bosche B, Ladilov Y, Schafer C, Piper HM, Noll T. Modulation of early [Ca2+]i rise in metabolically inhibited endothelial cells by xestospongin C. Am J Physiol Heart Circ Physiol 2001; 280: 1002-10.
25. Trochon V, Blot E, Cymbalista F, Engelmann C, Tang RP, Thomaidis A, Vasse M, Soria J, Lu H, Soria C. Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. Int J Cancer 2000; 85: 691-6.
26. Kuhlmann CR, Trumper JR, Abdallah Y, Wiebke Ludders D, Schaefer CA, Most AK, Backenkohler U, Neumann T, Walther S, Piper HM, Tillmanns H, Erdogan A. The K+-channel opener NS1619 increases endothelial NO-synthesis involving p42/p44 MAP-kinase. Thromb Haemost 2004; 92: 1099-107.
27. Kuhlmann CR, Gast C, Li F, Schafer M, Tillmanns H, Waldecker B, Wiecha J. Cerivastatin activates endothelial calcium-activated potassium channels and thereby modulates endothelial nitric oxide production and cell proliferation. J Am Soc Nephrol 2004; 15: 868-75.
28. Heller R, Polack T, Grabner R, Till U. Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis 1999; 144: 49-57.
29. Dimmeler S, Flemming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-5.
30. Fukumura D, Kashiwagi S, Jain RK. The role of NO in tumour progression. Nat Rev Cancer 2005; 6: 521-34.
31. Pervin S, Singh R, Freije WA, Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: Implications in breast cancer. Cancer Res 2003; 63: 8853-60.